Welcome and Introduction
Dr. Oliver Grottke – Aachen, Germany
Factor I the First to Replace?
Dr. Dietmar Fries – Innsbruck, Austria
Is It Time to Replace Plasma With 4F-PCC in Cardiac Surgery?
Dr. Keyvan Karkouti – Toronto, Canada
Addressing Challenges in Surgery
Dr. Oliver Grottke – Aachen, Germany
Q&A
Learning Objectives:
By the end of this symposium, participants will be able to identify key challenges in surgical bleeding management, understand the rationale for prioritizing early fibrinogen (Factor I) replacement, and evaluate current clinical evidence supporting the use of 4-factor prothrombin complex concentrate (4F-PCC) as a superior option to FP on efficacy and safety for patients undergoing cardiac surgery with coagulopathic bleeding, with the goal of optimizing haemostatic strategies and improving patient outcomes.
NATA: Network for the advancement of Patient Blood Management, Haemostasis and Thrombosis
MISSION: Providing a multidisciplinary forum for dialogue between haematologists, transfusion medicine specialists, anaesthesiologists, intensive care and emergency physicians, surgeons, perfusionists, nurses, biomedical scientists and ther healthcare professionals.
I am text block. Click edit button to change this text. Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.